Status:
UNKNOWN
COVID-19 Prevalence in UNIVI Geriatric Institutions: Epidemiological Study of Immunological Status With Rapid Serological Tests
Lead Sponsor:
Centre Médical Porte Verte
Conditions:
COVID-19
Eligibility:
All Genders
Brief Summary
To date, little information is available on the prevalence of Covid-19 and data are lacking on the proportion of patients, institutional residents and caregivers who have actually been exposed to SARS...
Detailed Description
Type of study: multicentric prospective observational Study location: 26 nursing homes and 4 geriatric hospitals belonging to the UNIVI Group in France Context: At the end of the Covid-19 containmen...
Eligibility Criteria
Inclusion
- Residents of participating nursing home - who benefited from a rapid diagnostic orientation serological test for COVID-19 - having given their agreement
- All staff members (doctors, nurses, health executives, caregivers, physiotherapists, ASH, stretcher bearers, psychologists, dieteticians, administrative staff, secretaries, ...) - who benefited from a rapid diagnostic orientation serologic test for COVID-19 - having given their agreement
Exclusion
- Refusal to participate
Key Trial Info
Start Date :
July 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 16 2021
Estimated Enrollment :
1145 Patients enrolled
Trial Details
Trial ID
NCT04790994
Start Date
July 24 2020
End Date
April 16 2021
Last Update
March 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CentreMédicalPorteVerte
Versailles, France, 78000